TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT02376673

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Children's Book
Description: A specially-designed, illustrated (full color) children's book written at a first-grade level, conveying American Academy of Pediatrics safe sleep guidelines through the story. Expanded guidelines are listed on the back cover, at a 4th grade reading level. This book will be exclusively used for safe sleep education at 3 study home visits: prenatal between 32 weeks and term, 1 week postnatal, and 2 months postnatal. The mother will be encouraged to share the book with her baby.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Brochures
Description: An assortment of standard safe sleep educational brochures provided by home visitors during prescribed home visits, covering various recommendations for safe sleep.
Study: NCT04521738

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SAR441255
Description: Pharmaceutical form:solution for injection~Route of administration: subcutaneous

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Pharmaceutical form:solution for injection~Route of administration: subcutaneous
Study: NCT04037709

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: scaling and root planing (SRP) + PDT placebo
Description: Patientes will receive periodontal treatment (scaling and root planing - SRP) with the ultrasound. The SRP will be done in one session. The PDT placebo wil be done using an agent with the same vehicle as that of the methylene blue to mimic irrigation with the photosensitizer; the laser will be switched off at the time of application.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: scaling and root planing (SRP) + PDT
Description: patients will receive the same scaling and root planing treatment that placebo group.However the PDT will be done only on one side of mouth using methylene blue 0.005% .The red laser diode (λ = 660 nm) will be applied with an output power of 100mW . The laser head will be positioned in direct contact with the pseudo periodontal pockets.
Study: NCT01810510

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PAV Ventilation
Description: PAV is a mode of ventilation in which the only set parameter is the proportion of work/effort that is provided regardless of the ventilatory pattern the patient chooses- the patient has full control over pressure, volume, flow and time of inspiration as well as respiratory rate. In this mode, the ventilator measures patient respiratory mechanics every 10-15 breaths and delivers a level of pressure proportional to patient effort, thereby maintaining a set proportion of patient effort regardless of the patient's ventilatory pattern. The patients will be on this mode of ventilation for 60 minutes.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: NAVA Ventilation
Description: With NAVA, delivery from the ventilator is triggered, controlled and cycled by the diaphragmatic EMG signal (Edi), which is measured by a specially designed nasogastric or orogastric catheter (NGT or OGT) containing EMG electrodes that cross the diaphragm. In this mode, the ventilator measures the Edi with each breath and instantaneously delivers a level of pressure proportional to Edi magnitude, thereby providing a set proportion of effort on a breath-to-breath basis. The patients will be on this mode of ventilation for 60 minutes.
Study: NCT03035578

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Morphine
Description: Sampling blood for development of Morphine Pharmacokinetic/Pharmacodynamic Model for Neonatal Population

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Morphine
Description: Sampling saliva for development of Morphine Pharmacokinetic/Pharmacodynamic Model for Neonatal Population
Study: NCT00720382

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 0.15% azelastine hydrochloride
Description: 1644 mcg (205.5 mcg/spray) 2 sprays per nostril twice a day/AM and PM

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mometasone furoate
Description: 200 mcg (50 mcg/spray) 2 sprays per nostril Once a day (AM)
Study: NCT01277159

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: A. Control Nerve Block. IV Dexamethasone (4 mg).
Description: A. Control Nerve Block. IV Dexamethasone (4 mg).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: B. Nerve Block with Dexamethasone (4 mg). IV saline.
Description: B. Nerve Block with Dexamethasone (4 mg). IV saline.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: C. Control Nerve Block. IV Dexamethasone (4 mg). IV Buprenorphine (0.3 mg)
Description: C. Control Nerve Block. IV Dexamethasone (4 mg). IV Buprenorphine (0.3 mg)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D. Nerve Block with Buprenorphine (0.3 mg). IV Dexamethasone (4 mg).
Description: D. Nerve Block with Buprenorphine (0.3 mg). IV Dexamethasone (4 mg).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: E. Nerve Block with Dexamethasone (4 mg) / block Buprenorphine (0.3 mg).
Description: E. Nerve Block with Dexamethasone (4 mg) / block Buprenorphine (0.3 mg). IV saline.
Study: NCT00351403

Intervention type: DRUG
Group type: OTHER
Intervention: Ribavirin
Description: Rebetol 200 mg: applied as hard capsule

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ribavirin
Description: Rebetol 200 mg: applied as hard capsule

Intervention type: DRUG
Group type: OTHER
Intervention: Peginterferon alfa 2b
Description: PegIntron (50/80/100/120/150 microgram): applied by injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Peginterferon alfa 2b
Description: PegIntron (50/80/100/120/150 microgram): applied by injection
Study: NCT00822692

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Trim/ Sulfa DS
Description: bactrim DS (800/160) two tablets PO BID x 7 days

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: matched placebo 2 pills PO BID x 7 days
Study: NCT03888963

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PRF
Description: patients will receive pulsed radiofrequency, 4 cycles (each cycle, 2 minutes) on the thoracic paravertebral nerves number 2,3, and 4 under fluroscopic guidance

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: SHAM
Description: patients will be subjected to the same procedure like PRF group without giving PRF
Study: NCT01711515

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Given IV

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: External Beam Radiation Therapy
Description: Undergo external beam radiation therapy

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Internal Radiation Therapy
Description: Undergo intracavitary brachytherapy

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Description: Given IV

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study: NCT04641598

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endometrial Scratch
Description: An endometrial biopsy pipelle will be used to create endometrial injury in the form of a scratch.

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham procedure
Description: Motions of performing an endometrial scratch will be performed including speculum placement and cervix cleansing, however, placement of the tenaculum and the endometrial scratch will not be performed.
Study: NCT01431365

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Moderate Exercise Group
Description: Participants will be required to walk briskly (equivalent to moderate intensity) on a treadmill for 10 minutes.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Passive Sitting Group
Description: Participants will be required to sit passively for 10 minutes on a chair.
Study: NCT04325932

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Urinary Kallikrein
Study: NCT03323242

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LigaSure
Description: The dissection of the small blood vessels and the connective tissue in the hepatoduodenal ligament is carried out with LigaSure

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Harmonic Ultrasonic dissector
Description: The dissection of the small blood vessels and the connective tissue in the hepatoduodenal ligament is carried out with Harmonic Ultrasonic dissector
Study: NCT04515381

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Therapeutic Touch
Description: Therapeutic Touch

Intervention type: OTHER
Group type: OTHER
Intervention: Control group
Description: Making measurements at the beginning of the research and 4 weeks

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Sham Therapeutic Touch
Description: Sham Therapeutic Touch
Study: NCT02171871

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exposed to a smoking environment
Description: Then the subjects will be exposed to a smoking environment for 20 minutes, under a continuous measurement of emitted particles using the SIDEPAK AM510 in Pm level 2,5=250, in a closed space of 20 m3. The passive smoking environment will be achieved via a smoking machine. Afterwards, the subject will again undergo IOS in four positions (standing, sitting, right and left lateral decubitus) and nitrogen washout test in two positions (sitting and decubitus). Thanks to the above mentioned techniques, changes in measured parameters will be evaluated.
Study: NCT05509075

Intervention type: DIETARY_SUPPLEMENT
Intervention: nutraceuticals
Description: antioxidants

Intervention type: DIETARY_SUPPLEMENT
Intervention: nutraceuticals
Description: antioxidants

Intervention type: DIETARY_SUPPLEMENT
Intervention: nutraceuticals
Description: antioxidants

Intervention type: DIETARY_SUPPLEMENT
Intervention: nutraceuticals
Description: antioxidants

Intervention type: DIETARY_SUPPLEMENT
Intervention: nutraceuticals
Description: antioxidants

Intervention type: DIETARY_SUPPLEMENT
Intervention: nutraceuticals
Description: antioxidants
Study: NCT00781807

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: multi-module rehabilitation program
Description: The multi-module rehabilitation program includes:~1. Nutrition management~2. Home-based ergometer training program~3. Psychosocial support
Study: NCT00676260

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pioglitazone
Description: Pioglitazone 15 mg to 30 mg, tablets, orally, once daily for up to 10 weeks

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Pioglitazone placebo-matching tablets, orally, once daily for up to 10 weeks
Study: NCT04578561

Intervention type: PROCEDURE
Intervention: Prophylactic mesh use
Description: After laparotomy sutured clousur the abdominal wall wound is reinforced using a suprafascial synthetic mesh.
Study: NCT01691976

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oestrogen Patches

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: LHRHa
Description: Luteinising hormone releasing-hormone agonists (LHRHa)
Study: NCT00576472

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Description: Please see detailed description for dosing information and study design.
Study: NCT03150277

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Plyometric exercise
Description: 2 sets of 10 ankle hops, 3 sets of 5 hurdle hops, 5 drop-jumps from a height of 50 cm

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Plyometric exercise
Description: 2 sets of 10 ankle hops, 3 sets of 5 hurdle hops, 5 drop-jumps from a height of 50 cm

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Heavy resistance exercise
Description: 10 single repetitions of back half squats at 90% of 1 repetition maximum

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Heavy resistance exercise
Description: 10 single repetitions of back half squats at 90% of 1 repetition maximum
Study: NCT02175368

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Adhese One F Upgrade
Study: NCT00519662

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SNS-314
Description: Stage 1 - Escalating doses of SNS-314 Injection on days 1, 8 and 15~Stage 2 - Same as stage 1 except SNS-314 Injection is administered at the maximum tolerated dose established in stage 1
Study: NCT03832608

Intervention type: OTHER
Intervention: No intervention
Description: There is not intervention to be administered, only collection of data through various tests and questionnaires.
Study: NCT01606033

Intervention type: OTHER
Group type: OTHER
Intervention: questionnaires
Description: Anxiety and depression questionnaire, life quality questionnaire, adjustment strategy questionnaire, emotional regulation questionnaire, satisfaction survey

Intervention type: OTHER
Group type: OTHER
Intervention: questionnaires
Description: Anxiety and depression questionnaire, life quality questionnaire, adjustment strategy questionnaire, emotional regulation questionnaire, satisfaction survey

Intervention type: OTHER
Group type: OTHER
Intervention: questionnaires
Description: Anxiety and depression questionnaire, life quality questionnaire, adjustment strategy questionnaire, emotional regulation questionnaire, satisfaction survey

Intervention type: OTHER
Group type: OTHER
Intervention: questionnaires
Description: Anxiety and depression questionnaire, life quality questionnaire, adjustment strategy questionnaire, emotional regulation questionnaire, satisfaction survey

Intervention type: OTHER
Group type: OTHER
Intervention: questionnaire
Description: understanding of the implications of participating in a clinical trial

Intervention type: OTHER
Group type: OTHER
Intervention: questionnaire
Description: understanding of the implications of participating in a clinical trial

Intervention type: OTHER
Group type: OTHER
Intervention: questionnaire
Description: understanding of the implications of participating in a clinical trial
Study: NCT03041363

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Triheptanoin
Description: Triheptanoin will be administered for 7 days 4 times daily.
Study: NCT02499042

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxygen
Description: oxygen delivery by ETT/ SGA connected to bag/valve/oxygen reservoir

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxygen
Description: oxygen delivery by ETT/ SGA connected to bag/valve/oxygen reservoir
Study: NCT03668405

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lu AF20513
Description: Injection
Study: NCT06203418

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multi-Family Therapy
Description: Multi family therapy for anorexia nervosa (MFT-AN) draws on the same principles as FBT but is delivered in a more intensive format to help families to overcome a sense of isolation and stigmatization and to maximize their own resources. In the case of eating disorders, this program utilizes FBT principles (both approaches are guided by the family-based treatment philosophy, which stresses the impact of ED on family functioning and attempts to mobilize families as the primary agents of change in achieving recovery), and also utilizes learning from structural, systemic, strategic, narrative, and psychodrama-based family therapy practices,(Knatz et al., 2015). Generally between 5-7 families take part in MFT, sharing their experiences, learning by example, and providing support for one another. Study will utilize virtual adaptation of manualized treatment published by Simic et al 2021
Study: NCT01818492

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: NI-0501
Study: NCT04418986

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: opposite clear corneal incisions (OCCI)
Description: Coaxial small incision cataract surgery was performed for all cases using a 2.8 mm keratome placed at steep meridian and 1-mm paracentesis was made 90 degrees apart with a 20-gauge microvitrectomy blade. Surgery was performed with a 30-degree, 0.9-caliper phacoemulsification tip (microtip) with a divide and conquer technique.~In the OCCI group, a single penetrating incision was created with 2.8 mm keratome in the clear cornea, 1.5 mm anterior to limbal blood vessels, centered over the steep meridian and opposite the phacoemulsification incision.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: opposite clear corneal incisions (OCCI)
Description: Coaxial small incision cataract surgery was performed for all cases using a 2.8 mm keratome placed at steep meridian and 1-mm paracentesis was made 90 degrees apart with a 20-gauge microvitrectomy blade. Surgery was performed with a 30-degree, 0.9-caliper phacoemulsification tip (microtip) with a divide and conquer technique.~In the OCCI group, a single penetrating incision was created with 2.8 mm keratome in the clear cornea, 1.5 mm anterior to limbal blood vessels, centered over the steep meridian and opposite the phacoemulsification incision.
Study: NCT01533454

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Financial Incentives
Description: Incentive arm participants will be able to earn incentives for meeting specified weight loss targets or step goals. They will be offered a choice between traditional (payments with certainty) and behavioral(payments paid via lottery) incentives.
Study: NCT01642017

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pazopanib
Description: Pazopanib will be administered orally at the starting dose of 400 mg/day in 28-days cycles ; barring limiting toxicities the dose of pazopanib will escalate in several steps (a maximum of 3 dose levels are defined : 400, 600 and 800 mg/day). The pazopanib will be administered at the same dosa until disease progression.
Study: NCT03974295

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Vaginal unprotected intercourse
Description: Patients will allowed to engage in vaginal unprotected intercourse as many times as desired after 24 hours of pelvic rest after a frozen embryo transfer.
Study: NCT02940483

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-Azacytidine
Description: 5-Azacytidine 10 mg into the fourth ventricle of the brain via the Ommaya reservoir 1 day a week for 12 weeks.
Study: NCT03841136

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: anlotinib
Description: anlotinib 12mg PO QD CBP(AUC 5mg/mL/min，or DDP（75mg/m2）D1 etoposide（100mg/m2）D1\~D3
Study: NCT00659503

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ciclesonide
Description: 200µg Ciclesonide versus Placebo

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo
Study: NCT00257660

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A
Description: 500 units

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 500 units
Study: NCT05303688

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: iv dexketoprofen trometamol (Arveles 50mg/2mL; UFSA, İstanbul, Turkey)
Description: The primary predictor variable was preventive analgesia group. Patients were randomly divided in two groups. 50 mg iv dexketoprofen trometamol (Arveles 50mg/2mL; UFSA, İstanbul, Turkey) were administrated 30 minutes before incision in the treatment group (dexketoprofen trometamol n= 15
Study: NCT03908723

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Panretinal photocoagulation
Description: Intravitreal Aflibercept with PRP to the peripheral vascular lesions
Study: NCT05303688

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Steril Salin (control)
Description: 30 minutes before incision in the treatment group (dexketoprofen trometamol n= 15) and iv sterile saline were administrated 30 minutes before incision in the placebo group (saline n= 15).
Study: NCT02901652

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: noninvasive respiratory support devices

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: noninvasive respiratory support devices
Study: NCT04627233

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Human Ezrin Peptide 1 (HEP1)
Description: HEP-1 will be administrated s.c. into the lower abdominal wall~1. induction dosage: 2 mg Ezrin in 2 ml physiological saline applied s.c.,one injection every 12 hours until symptoms disappear followed by~2. maintenance dosage: 0.2 mg Ezrin in 1 ml physiological saline solution s.c 1/day for 10 days
Study: NCT02323152

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: psychoeducation
Description: Usual treatment + psychoteraphy focused on problem solving (6 sessions). The psychoeducational programme consists of 6 sessions of 60 minutes, one per week.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard care
Description: Puerperal control with their doctor. This group will also be interviewed with the same frecuency of the experimental group but will not receive a psichologycal treatment
Study: NCT01869660

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Shared Decision Making
Description: The focus of the SDM is to empower patients to discuss their attitudes and preferences toward treatments.
Study: NCT03683888

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HealthSnap
Description: HealthSnap provides personalized lifestyle reports and track progress over time using an electronic lifestyle record (ELR). HealthSnap Assessment is a simple, quick and not invasive tool that uses an algorithm that includes a questionnaire, physical measurements, dietary data and body fat indices

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: dietary counseling
Description: Dietary counseling by RD. Low Calorie and/or Low Carb dietary plans will be discussed and provided to the study participant